424 related articles for article (PubMed ID: 11882685)
1. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
3. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
4. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
5. Single-molecule kinetics of pore assembly by the membrane attack complex.
Parsons ES; Stanley GJ; Pyne ALB; Hodel AW; Nievergelt AP; Menny A; Yon AR; Rowley A; Richter RP; Fantner GE; Bubeck D; Hoogenboom BW
Nat Commun; 2019 May; 10(1):2066. PubMed ID: 31061395
[TBL] [Abstract][Full Text] [Related]
6. Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex.
Moskovich O; Fishelson Z
J Biol Chem; 2007 Oct; 282(41):29977-86. PubMed ID: 17644516
[TBL] [Abstract][Full Text] [Related]
7. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
[TBL] [Abstract][Full Text] [Related]
8. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
Husler T; Lockert DH; Sims PJ
Biochemistry; 1996 Mar; 35(10):3263-9. PubMed ID: 8605162
[TBL] [Abstract][Full Text] [Related]
9. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59.
Hamilton KK; Ji Z; Rollins S; Stewart BH; Sims PJ
Blood; 1990 Dec; 76(12):2572-7. PubMed ID: 1702330
[TBL] [Abstract][Full Text] [Related]
10. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
11. Formation of ion-conducting channels by the membrane attack complex proteins of complement.
Shiver JW; Dankert JR; Esser AF
Biophys J; 1991 Oct; 60(4):761-9. PubMed ID: 1720679
[TBL] [Abstract][Full Text] [Related]
12. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
13. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
Fu X; Ju J; Lin Z; Xiao W; Li X; Zhuang B; Zhang T; Ma X; Li X; Ma C; Su W; Wang Y; Qin X; Liang S
Sci Rep; 2016 Jul; 6():30239. PubMed ID: 27444648
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane channel-formation by five complement proteins.
Müller-Eberhard HJ
Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
[TBL] [Abstract][Full Text] [Related]
15. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
16. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement.
Whitlow MB; Iida K; Stefanova I; Bernard A; Nussenzweig V
Cell Immunol; 1990 Mar; 126(1):176-84. PubMed ID: 1689219
[TBL] [Abstract][Full Text] [Related]
17. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
Zalman LS; Müller-Eberhard HJ
Mol Immunol; 1990 Jun; 27(6):533-7. PubMed ID: 1696352
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructure of the membrane attack complex of complement. Heterogeneity of the complex caused by different degree of C9 polymerization.
Tschopp J
J Biol Chem; 1984 Jun; 259(12):7857-63. PubMed ID: 6736027
[TBL] [Abstract][Full Text] [Related]
19. Channel fluctuations induced by membrane attack complex C5B-9.
Young JD; Young TM
Mol Immunol; 1990 Oct; 27(10):1001-7. PubMed ID: 1700284
[TBL] [Abstract][Full Text] [Related]
20. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
